US20260308499
2026-10-08
Chemistry; metallurgy
C12M21/08
The disclosed 3D printing method utilizes a droplet printer for creating high-resolution, photorealistic prints, combined with a device for applying electromagnetic waves. A novel capillary ink is used, which crosslinks or forms layers only at the ink drop edges, leaving unbound components to be removed. This process creates a capillary network with diameters up to approximately 10 μm. Additionally, a unique printer table and printer head supply unit are introduced to ensure the printed tissue is nourished and the bio-inks are mixed accurately.
The method introduces several key innovations:
Existing 3D printing systems lack the capabilities to create viable large tissues and organs due to limitations in resolution and cell type selectivity. Current methods either achieve high resolution without selective printing or allow simultaneous printing of different cell types but lack the necessary resolution. Techniques like Laser Induced Forward Transfer and stereolithography offer high resolution but are slow and limited to small structures. Other methods leave space for vessels but require transformation into an organism to form capillaries, a process that can take days and does not achieve natural tissue complexity.
The new method addresses these challenges by allowing selective printing of different cell types in one step while achieving high resolution akin to stereolithography. It also offers a rapid printing speed suitable for whole organs and includes a system for flushing newly formed tissue with nutrient medium during printing. The process creates a capillary system between arterial and venous structures, allowing fluid flow from arterial to venous, essential for organ viability.
This innovative method has significant implications for organ transplantation, reducing the dependency on donor organs, and for research and pharmacy, potentially replacing millions of animal experiments. It also advances regenerative medicine by enabling the printing of complex tissues and organs, offering new solutions for patients awaiting transplants and contributing to medical research and treatment development.